3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Gastrointestinal
1
Conditions
Barrett Esophagus
1
Adenocarcinoma Of Esophagus
1
Interventions
Oxaliplatin
778
Fluorouracil
637
Capecitabine
573
Gemcitabine
478
Leucovorin
458
Irinotecan
444
Bevacizumab
443
Cisplatin
337
Radiotherapy
282
Cetuximab
251
Paclitaxel
180
S 1 (combination)
175
pembrolizumab
173
Docetaxel
156
Drug Therapy
147
Nivolumab
146
sintilimab
143
tislelizumab
130
apatinib
130
130-nm albumin-bound paclitaxel
127
Folfox protocol
120
durvalumab
119
Albumin-Bound Paclitaxel
117
camrelizumab
107
lenvatinib
106
Panitumumab
106
Surgical Procedures, Operative
102
regorafenib
101
Sorafenib
99
Radiation
88
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Spectrum Analysis
×
Gastrointestinal
×
Clear all
NCT05745857
2026-04-13
SLURP
University Medical Center Groningen
Phase 2
Recruiting
25 enrolled